Patent 7850962 was granted and assigned to Genmab A/S on December, 2010 by the United States Patent and Trademark Office.
Isolated human monoclonal antibodies which bind to and inhibit human CD20, and related antibody-based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the human antibodies, and therapeutic and diagnostic methods for using the human antibodies.